Dopamine Beta-Hydroxylase Deficiency

Watchlist

(log in to enable)

Retrieved

2021-01-23

Source

Orphanet

Trials

—

Genes

DBH, ATOX1, CYB561, NPY, TH

Drugs

Droxidopa ( NORTHERA ), L-threo-3,4-dihydroxyphenylserine, Midodrine hydrochloride ( AMATINE )

Interested in hearing about new therapies?

Dopamine beta-hydroxylase deficiency is an extremely rare genetic metabolic disorder characterized by autonomic dysregulation leading mainly to orthostatic hypotension.